文献速递临床试验与 GCP

连续联合口服避孕药对比维生素E治疗月经性偏头痛:一项随机对照试验的原理与方案(WHAT!)

Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!).
PubMed 文献 · Trials · 2024-02-15

该随机对照试验计划纳入180名月经性偏头痛女性,按1:1随机分配至炔雌醇/左炔诺孕酮30/150微克组或维生素E 400国际单位组,经过4周基线期后治疗12周,使用电子头痛日记记录。主要结局为每月偏头痛天数从基线(第-4至0周)至治疗最后4周(第9至12周)的变化,次要结局包括每月头痛天数变化及50%应答率。

要点

  • 目前缺乏偏头痛的循证激素治疗,小型研究提示联合口服避孕药可能有效,但尚无大型随机对照试验。
  • 该试验纳入180名月经性偏头痛女性,随机比较连续联合口服避孕药与维生素E。
  • 主要结局为每月偏头痛天数从基线至治疗最后4周的变化。

核心结论

  • WHAT!试验旨在研究连续联合口服避孕药治疗月经性偏头痛的有效性和安全性。
  • 作者认为结果可能立即应用于临床实践。

研究设计与样本

  • 随机对照试验,纳入月经性偏头痛女性180名,按1:1随机分配至炔雌醇/左炔诺孕酮30/150微克组或维生素E 400国际单位组。
  • 参与者先经历4周基线期,随后进行12周治疗期,使用时间锁定且包含自动算法区分头痛和偏头痛日的电子头痛日记。

主要发现

  • 主要结局为每月偏头痛天数从基线(第-4至0周)至治疗最后4周(第9至12周)的变化。
  • 次要结局为每月头痛天数的变化以及每月偏头痛天数和每月头痛天数的50%应答率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, there is no evidence-based hormonal treatment for migraine in women. Several small studies suggest a beneficial effect of combined oral contraceptives, but no large randomized controlled trial has been performed. As proof of efficacy is lacking and usage may be accompanied by potentially severe side effects, there is a great need for clarity on this topic. METHODS: Women with menstrual migraine (n = 180) are randomly assigned (1:1) to ethinylestradiol/levonorgestrel 30/150 μg or vitamin E 400 IU. Participants start with a baseline period of 4 weeks, which is followed by a 12-week treatment period. During the study period, a E-headache diary will be used, which is time-locked and includes an automated algorithm differentiating headache and migraine days. RESULTS: The primary outcome will be change in monthly migraine days (MMD) from baseline (weeks - 4 to 0) to the last 4 weeks of treatment (weeks 9 to 12). Secondary outcomes will be change in monthly headache days (MHD) and 50% responder rates of MMD and MHD. CONCLUSIONS: The WHAT! trial aims to investigate effectivity and safety of continuous combined oral contraceptive treatment for menstrual migraine. Immediate implementation of results in clinical practice is possible. TRIAL REGISTRATION: Clinical trials.gov NCT04007874 . Registered 28 June 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van der Arend BWH, van Casteren DS, Verhagen IE, et al. Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!). Trials. 2024. PMID: 38360739. doi:10.1186/s13063-024-07955-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。